StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for VIMOVO-Related Patent
March 14, 2016 7:19 AM
Horizon Pharma plc (Nasdaq: HZNP) announced the issuance of a Notice of Allowance from the United States Patent and Trademark ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Litigation
Management Comments
Next Articles
Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for RAVICTI-Related Patent App
March 16, 2016 7:05 AM
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
March 14, 2016 7:00 AM